COMPOSITIONS FOR USE AS A PROPHYLACTIC AGENT TO THOSE AT RISK OF INFECTION OF TUBERCULOSIS, OR AS SECONDARY AGENTS FOR TREATING INFECTED TUBERCULOSIS PATIENTS

• 1. 用作有结核感染风险的患者的预防剂或用作治疗结核感染患者的辅助剂的组合物 [P] . 中国专利： CN112449604A . 2021-03-05
• 2. 结核病组合物和治疗或预防结核病的方法 [P] . 中国专利： CN109890411A . 2019-06-14
• 3. Compositions for use as a prophylactic agent to those at risk of infection of tuberculosis, or as secondary agents for treating infected tuberculosis patients [P] . AU2019221709A1 . 2020-10-15

  机译： 用作对有感染结核病风险的人的预防剂，或作为治疗感染结核病患者的辅助剂的组合物

• 4. COMPOSITIONS FOR USE AS A PROPHYLACTIC AGENT TO THOSE AT RISK OF INFECTION OF TUBERCULOSIS, OR AS SECONDARY AGENTS FOR TREATING INFECTED TUBERCULOSIS PATIENTS [P] . 世界知识产权组织专利： WO2019158779A1 . 2019-08-22

  机译： 用作感染结核病风险的预防性药物的组合物，或用作治疗感染结核病患者的辅助制剂的组合物

• 5. Composition used as a secondary agent for treating infected tuberculosis patients or as a preventative agent for persons with risk of tuberculosis infection [P] . JP2021514392A . 2021-06-10

  机译： 用作治疗受感染的结核病患者的二级剂或作为具有结核感染风险的人的预防剂的组成

• 1. Structure-based design,synthesis of novel inhibitors of Mycobacterium tuberculosis FabH as potential anti-tuberculosis agents [J] . Xue Hui Zhang, Hong Yu, Wu Zhong, 中国化学快报（英文版） . 2009,第009期
• 2. Prevalence and Risk Factors Associated with Adverse Drug Reactions among Previously Treated Tuberculosis Patients in China [J] . HAN Xi Qin, PANG Yu, MA Yan, 生物医学与环境科学（英文版） . 2017,第002期
• 3. Latent tuberculosis infection and tuberculosis in patients with rheumatic diseases treated with anti-tumor necrosis factor agents [J] . Garziera Giovana, Bittencourt Morsch Andre Luis, Otesbelgue Felipe, Clinical rheumatology . 2017,第8期
• 4. Quantiferon TB Gold and tuberculin skin tests for the detection of latent tuberculosis infection in patients treated with tumour necrosis factor alpha blocking agents [J] . M. Klein, K. Jarosova, S. Forejtova, Clinical and experimental rheumatology . 2013,第1期
• 5. Serial Interferon-gamma Release Assays for the Diagnosis of Latent Tuberculosis Infection in Patients Treated with Immunosuppressive Agents [J] . Annals of laboratory medicine. . 2011,第4期
• 6. Mycobacterium tuberculosis Antigen-Specific IL-2R and IP-10 Expression Changes in Chronic Obstructive Pulmonary Disease Patients with in Latent Tuberculosis Infection [C] . Sungyong Bong, Sunghyun Kim, Joo Hwan Hwang, International Molecular Medicine Tri-Conference. . 2016
• 7. Part I. Development of new organic synthetic methods: Palladium and copper catalyzed carbon-carbon, carbon-sulfur, carbon-nitrogen, and carbon-oxygen bond formation as well as DABCO-mediated stereospecific synthesis of acrylate ethers and amines. Part II. Design, synthesis and SAR studies of new classes of agents to treat drug-resistant bacteria, anthrax and tuberculosis infections. [D] . Kabir, Mohd Shahjahan. 2011
• 8. Serial Interferon-gamma Release Assays for the Diagnosis of Latent Tuberculosis Infection in Patients Treated with Immunosuppressive Agents [O] . Kyeong-Hee Kim, Sung-Won Lee, Won-Tae Chung, 2011

• 1. Significant risk and associated factors of active tuberculosis infection in Korean patients with inflammatory bowel disease using anti-TNF agents [J] . Eun Soo Kim ,Geun Am Song ,Kwang Bum Cho . 世界胃肠病学杂志：英文版 . 2015,第11期
• 2. Abdominal Sonographic Findings in Severely Immunosuppressed Human Immunodeficiency Virus-Infected Patients Treated for Tuberculosis [J] . Harriet Nalubega Kisembo ,Michael Grace Kawooya ,Chris Kenyon . 结核病研究（英文） . 2014,第2期
• 3. Effect of anti-tuberculosis therapy on liver function of pulmonary tuberculosis patients infected with hepatitis B virus [J] . LeiPan ,Zhan-ShengJia ,LinChen . 世界胃肠病学杂志：英文版 . 2005,第16期
• 4. 纳米CeO2、TiO2粒子组合物用作润滑油添加剂的摩擦学性能研究 [C] . 李磊 ,顾卓明 ,顾彩香 . 第八届全国摩擦学大会 . 2007
• 5. 纳米二氧化铈、铁粒子组合物用作润滑油添加剂的摩擦学性能和机理研究 [A] . 许军 . 2007